Your browser doesn't support javascript.
loading
[Efficacy and safety of daratumumab in the treatment of advanced light chain amyloidosis].
Shen, K N; Miao, H L; Gao, Y J; Cao, X X; Zhou, D B; Su, W; Li, J.
Afiliação
  • Shen KN; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Miao HL; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Gao YJ; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Cao XX; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Zhou DB; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Su W; Laboratory Department, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Li J; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Zhonghua Xue Ye Xue Za Zhi ; 43(1): 31-34, 2022 Jan 14.
Article em Zh | MEDLINE | ID: mdl-35231990

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amiloidose de Cadeia Leve de Imunoglobulina / Anticorpos Monoclonais Idioma: Zh Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amiloidose de Cadeia Leve de Imunoglobulina / Anticorpos Monoclonais Idioma: Zh Ano de publicação: 2022 Tipo de documento: Article